Results 191 to 200 of about 2,712,287 (341)
Abstract Objectives This study aimed to evaluate the effects of different types and combinations of exercise on migraine attacks and accompanying comorbidities. Background Combining aerobic and resistance exercises may yield more significant improvements in patients with migraine.
Yunus Emre Meydanal+2 more
wiley +1 more source
Neuromodulation in Chronic Migraine: Evidence and Recommendations from the GRADE Framework. [PDF]
Tana C+6 more
europepmc +1 more source
Abstract Objective The study compared middle‐aged and older Canadians with and without migraine, examining how self‐perceptions of health, cognition, and pain relate to objective health metrics. Background Migraine, a debilitating neurological disorder, affects 8.3% of Canadians and 14.0% of the global population.
Makenna K. N. Jensen+2 more
wiley +1 more source
A comparison of the efficacy of bilateral and unilateral pulsed radiofrequency treatments in the management of chronic migraine. [PDF]
Karaduman Y+5 more
europepmc +1 more source
Erratum to: Greater occipital nerve block in chronic migraine [PDF]
Maria Gabriella Saracco+3 more
openalex +1 more source
Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine
Abstract Objective The primary objective was to characterize the pharmacokinetics (PK) and safety of eptinezumab in children and adolescents with migraine. Background Migraine in children and adolescents is a prevalent and potentially debilitating disease, and few preventive therapies are approved for use in these populations. Eptinezumab, a calcitonin
Andrew D. Hershey+4 more
wiley +1 more source
Economic impact of acupuncture for the prevention of episodic migraine and chronic migraine in Taiwan. [PDF]
Wu EC+3 more
europepmc +1 more source
Botox for the prophylaxis of headaches in chronic migraine [PDF]
Steve Chaplin, E. Anne MacGregor
openalex +1 more source
Abstract Objectives This study was conducted among participants with episodic migraine, to (i) assess patient preferences for attributes associated with calcitonin gene‐related peptide‐targeting therapies to prevent migraine and (ii) predict the probability that a real‐world patient would prefer an atogepant‐like treatment profile over monoclonal ...
Richard B. Lipton+5 more
wiley +1 more source